# VENLAFAXINE HYDROCHLORIDE
> **ANDA214609** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2021-06-30
## Drug
- **FDA Application Number:** ANDA214609
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VENLAFAXINE HYDROCHLORIDE
- **Generic name:** VENLAFAXINE
- **Active ingredients:** VENLAFAXINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Dr. Reddy's Laboratories Inc.
- **First approval:** 2021-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214609)
---
*MORVS · CC0 1.0*